dichlorphenamide has been researched along with Diabetic Glomerulosclerosis in 1 studies
Dichlorphenamide: A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
diclofenamide : A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skøtt, P | 1 |
| Hommel, E | 1 |
| Arnold-Larsen, S | 1 |
| Parving, HH | 1 |
1 other study available for dichlorphenamide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effect of carbonic anhydrase inhibitors on glomerular filtration rate in diabetic nephropathy.
Topics: Adult; Diabetic Nephropathies; Dichlorphenamide; Female; Glomerular Filtration Rate; Humans; Male | 1987 |